What are the dose thresholds that define moderate- and high-dose vasopressors for agents such as norepinephrine, epinephrine, vasopressin, phenylephrine, dopamine, and dobutamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Moderate to High Dose Vasopressor Thresholds

There are no universally standardized definitions for "moderate" or "high-dose" vasopressors in clinical guidelines, but based on clinical practice patterns and research data, high-dose vasopressors can be operationally defined as norepinephrine ≥0.5-0.7 mcg/kg/min (or norepinephrine-equivalents), with specific thresholds varying by individual agent.

Practical Dose Thresholds by Agent

Norepinephrine (First-line agent)

  • Moderate dose: 0.2-0.5 mcg/kg/min
  • High dose: ≥0.5-0.7 mcg/kg/min
  • The 90th percentile of maximum dosing in clinical practice is 0.5 mcg/kg/min, and the overall 90th percentile for combined vasopressor support (norepinephrine-equivalents) is 0.7 mcg/kg/min 1
  • Some patients receive doses up to 2.0 mcg/kg/min (99th percentile), though this represents extreme vasopressor requirements 1

Epinephrine (Second-line agent)

  • Moderate dose: 0.1-0.3 mcg/kg/min
  • High dose: ≥0.5 mcg/kg/min
  • The 90th percentile cutoff for maximum epinephrine dosing is 0.5 mcg/kg/min 1
  • Guidelines recommend adding epinephrine to norepinephrine when additional vasopressor support is needed 2

Vasopressin (Adjunctive agent)

  • Standard dose: 0.03-0.04 units/min (fixed dose, not weight-based)
  • High dose: >0.04 units/min or 3.6 units/hour
  • The 90th percentile for vasopressin is 3.6 units/hour (0.06 units/min) 1
  • Critical caveat: Guidelines explicitly state that vasopressin doses >0.03-0.04 units/min should be reserved for salvage therapy only 2
  • Vasopressin is not recommended as a single initial vasopressor 2

Phenylephrine (Alternative agent)

  • Moderate dose: 100-200 mcg/min
  • High dose: ≥316.5 mcg/min
  • The 90th percentile cutoff is 316.5 mcg/min 1
  • FDA labeling indicates dosing ranges from 0.5-6 mcg/kg/min for vasodilatory shock 3
  • Important limitation: Phenylephrine is not recommended as first-line therapy and should be reserved for specific circumstances (norepinephrine-associated arrhythmias, high cardiac output states, or salvage therapy) 2

Dopamine (Rarely used)

  • Moderate dose: 5-10 mcg/kg/min
  • High dose: ≥15 mcg/kg/min
  • The 90th percentile is 15.0 mcg/kg/min 1
  • Critical caveat: Dopamine is only recommended for highly selected patients (low risk of tachyarrhythmias, absolute or relative bradycardia) due to increased arrhythmic events 4, 2
  • Low-dose dopamine (<5 mcg/kg/min) should never be used for renal protection 2

Dobutamine (Inotrope, not vasopressor)

  • Standard dose: 2.5-10 mcg/kg/min
  • High dose: 15-20 mcg/kg/min
  • FDA labeling indicates usual range of 2-20 mcg/kg/min, with rare cases requiring up to 40 mcg/kg/min 5
  • Used for persistent hypoperfusion despite adequate fluid loading and vasopressor use 2

Norepinephrine-Equivalent (NEQ) Conversion Formula

When combining multiple vasopressors, calculate total vasopressor burden using this formula 6:

NEQ (mcg/kg/min) = norepinephrine + epinephrine + (phenylephrine/10) + (dopamine/100) + (metaraminol/8) + (vasopressin × 2.5) + (angiotensin II × 10)

Note: All doses in mcg/kg/min except vasopressin in units/min

Clinical Context and Interpretation

When to Consider Doses "High"

  • Combined NEQ ≥0.7 mcg/kg/min represents the 90th percentile of practice and should trigger consideration of additional interventions 1
  • Patients receiving high-dose vasopressors have significantly worse outcomes (31.6% hospital survival vs 79.7% for lower doses), though some patients survive even with very high doses 1

Algorithmic Approach to Escalation

  1. Start with norepinephrine as first-line agent 2
  2. At norepinephrine 0.2-0.3 mcg/kg/min: Add vasopressin 0.03 units/min (may reduce norepinephrine requirements) 2
  3. At norepinephrine 0.5 mcg/kg/min: Consider adding epinephrine or switching to epinephrine 2
  4. If combined NEQ approaches 0.7 mcg/kg/min: Reassess volume status, consider corticosteroids, evaluate for other causes of refractory shock, and consider mechanical circulatory support

Important Caveats

  • No survival benefit has been definitively demonstrated for any specific vasopressor choice; recommendations are based on safety profiles and organ dysfunction effects 4
  • Institutional variation is substantial: The percentage of patients receiving high-dose vasopressors ranges from 3.6% to 32.1% across different ICUs, even after adjusting for severity of illness 1
  • Vasopressin synergy with corticosteroids: Some evidence suggests synergistic survival benefit when combining vasopressin with hydrocortisone, though this is not consistently demonstrated 4
  • Renal considerations: Non-catecholamine vasopressors (vasopressin, angiotensin II) may have renal protective effects compared to catecholamines 7

References

4
Guideline

a global perspective on vasoactive agents in shock.

Intensive Care Medicine, 2018

Related Questions

Can you provide the step‑by‑step infusion rate conversion calculations for norepinephrine, epinephrine, dopamine, phenylephrine, and vasopressin for a 70‑kg adult patient?
How should norepinephrine 4 mg be prepared in 250 mL 5% dextrose in water (D5W), what is its indication, and what formula is used to calculate the infusion dose and rate?
In a hypotensive gunshot‑victim patient, which vasopressor (norepinephrine or dopamine) is the preferred choice?
What are the different types of vasopressors (pressors)?
In a 49-year-old woman with acute liver failure from acetaminophen toxicity who remains hypotensive (70/40 mm Hg) with sinus tachycardia after adequate fluid resuscitation, what is the most appropriate first-line vasopressor?
What is the difference between a posterior vitreous detachment (PVD) and a retinal detachment, and can a PVD lead to a retinal detachment?
What could cause a patient's blood pressure to fluctuate substantially from day to day despite consistent antihypertensive medication adherence and no significant changes in diet or sodium intake?
Why do floaters become more noticeable in bright sunlight after a posterior vitreous detachment?
Does polycythemia vera cause abdominal cramping and pain during intercourse?
Can aspirin be co-administered with omeprazole to reduce gastrointestinal irritation in patients requiring low-dose antiplatelet therapy?
What is a concise microdose buprenorphine induction protocol for a woman who uses 10 bags of street heroin/fentanyl daily, has no other health problems, and wants to avoid precipitated withdrawal and functional impairment, including guidance on tapering the heroin/fentanyl and the daily buprenorphine dosing schedule?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.